FridayJun 14, 2024 11:30 am

QualityStocksNewsBreaks – Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Targeting Significant Untapped Potential of Its Albert Lake Project

Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) is an exploration company that is targeting magmatic nickel sulfide discoveries to support the rapidly growing global electric vehicle market. While North America is deeply dependent on foreign nickel, which is a position of weakness for meeting EV and carbon goals, Canada has the potential to once again be a dominant player in nickel production thanks to companies like Fathom Nickel. “Fathom boasts over 113,000 hectares of prime exploration ground within a region consistently ranked among the top five for mineral exploration by the Fraser Institute. One of Fathom’s key projects, the…

Continue Reading

FridayJun 14, 2024 10:40 am

QualityStocksNewsBreaks – Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) Leveraging Promising Nickel-Copper-Cobalt Mineral Resource

Tartisan Nickel (CSE: TN) (OTCQB: TTSRF), a Canadian mineral exploration and mining development company, originally released a Preliminary Economic Assessment (“PEA”) report for its 100%-owned Kenbridge Nickel Project in 2022. “Drilling and assay results provided by Tartisan and compiled, verified and validated by P&E Mining Consultants Inc. were used to create an updated MRE, which confirmed that the Kenbridge Project ‘contains a significant nickel-copper-cobalt mineral resource that is potentially amenable to underground mining.’ The PEA noted that the measured and indicated mineral resources represent 3,508,000 tons at 0.70% Ni, 0.35% Cu, and 0.01% Co, while inferred mineral resources represent 1,013,000…

Continue Reading

FridayJun 14, 2024 10:33 am

QualityStocksNewsBreaks – Kidpik Corp. (NASDAQ: PIK) Announces $2M Private Placement

Kidpik (NASDAQ: PIK), a children's clothing subscription box company, has entered into a securities purchase agreement (“SPA”) with EF Hutton YA Fund LP. According to information filed with the U.S. Securities and Exchange Commission (“SEC”), the agreement calls for Kidpik to sell three tranches of convertible debentures totaling an aggregate principal amount of $2 million. The first tranche, valued at $500,000 was completed on May 18, 2023. Kidpik also agreed to sell an additional $500,000 in convertible debentures upon the filing of a definitive proxy statement with the SEC seeking stockholder approval for, among other things, a merger with Nina Footwear…

Continue Reading

FridayJun 14, 2024 9:45 am

Astrotech Corp. (NASDAQ: ASTC) Expands Role of Mass Spectrometry in Industrial Processes

In the chemical manufacturing industry, innovative uses of mass spectrometry are a game-changer by ensuring quality control, increased yields, and increased profits Astrotech subsidiary, Pro-Control Inc., has positioned its product line between the need for the chemical manufacturers to offset lower prices with efficiency gains that could offset potential losses The Pro-Control Maximum Value Processing(TM) can perform in-situ process tests every 5 minutes greatly increasing efficiency across a wide range of chemical manufacturing processes Mass spectrometry (“MS”) is becoming a transformative analytical technique that has revolutionized how materials are tested and processed in various industries, such as petrochemical. The supreme…

Continue Reading

FridayJun 14, 2024 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Advances Therapies Targeting Neurodegenerative Diseases

INM is advancing INM-089 targeting age-related macular degeneration and INM-901 targeting Alzheimer’s disease The company recently posted positive results for INM-089 demonstrating significant functional and pathological improvements in an AMD disease model Recent preclinical data for INM-901 displayed positive pharmacological effects for treating Alzheimer's disease INM posted a business update for Q3-2024 reporting a closing cash position of US$7.9 million and revenue growth for subsidiary BayMedica, a supplier of rare cannabinoids as ingredients InMed Pharmaceuticals (NASDAQ: INM), a is a clinical stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors. InMed’s…

Continue Reading

ThursdayJun 13, 2024 3:11 pm

QualityStocksNewsBreaks – ECGI Holdings Inc. (ECGI) Signs Binding LOI to Acquire Pacific Saddlery

ECGI Holdings (OTC: ECGI), a diversified holding company with a unique portfolio in viticulture and luxury fashion, is announcing the signing of a binding Letter of Intent (“LOI”) to acquire all outstanding shares of Pacific Saddlery, Inc., a renowned manufacturer and retailer of luxury equestrian tack, apparel and accessories, in exchange for $5,000,000 in ECGI-restricted shares. According to the announcement, these shares will remain restricted until ECGI uplists to a national exchange. The acquisition aligns with ECGI’s objectives of expanding its presence in the luxury brands sector. It is expected to generate new recurring revenue streams and enhance ECGI’s position…

Continue Reading

ThursdayJun 13, 2024 2:45 pm

QualityStocksNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Delivering Cutting-Edge Technology, Positioning in Electronic Monitoring Space

SuperCom Ltd. (NASDAQ: SPCB) is a digital security solutions innovator focused on the market for monitoring criminal offenders and tracking for public security. “Electronic-monitoring security solutions developer SuperCom is devoted to using technology to limit the threat of stalking-related violence by working with criminal justice systems, consumers and government-level security experts, and providing effective monitoring, offender tracking and rehabilitation reinforcement programs to promote public safety. The company is currently employing its innovative PureOne solution to deliver an all-in-one field-proven RFID and mobile technology and product suite that is growing with the addition of GPS technologies,” a recent article reads. “Our…

Continue Reading

ThursdayJun 13, 2024 2:04 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Subsidiary Secures $13.2M Sales Order

Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, today announced that its subsidiary, Bollinger Motors, has reached an agreement to sell 80 all-electric Class 4 commercial trucks for a sales order of $13.2 million to Momentum Groups, a leader in fleet management and EV charging solutions. Momentum, with strength is in its full-service national fleet program and mobile or permanent charging infrastructure for EVs, can upfit the Bollinger B4 Chassis Cab with mobile EV chargers, a box truck, flatbed, service body or stake truck. According to the announcement, Momentum will take possession of the vehicles after Bollinger Motors launches…

Continue Reading

ThursdayJun 13, 2024 1:48 pm

QualityStocksNewsBreaks – Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF) Announces Annual Shareholder Meeting, Outlines Agenda Items for Voting

Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF), a leading gold explorer in the Guiana Shield, has scheduled an annual general and special shareholders meeting. The meeting will be held July 9, 2024, with agenda items that include voting and approving an arrangement with G Mining Ventures. According to the announcement, shareholders will vote to approve a statutory plan of arrangement entered into between Reunion Gold, G Mining Ventures Corp. and Greenheart Gold Inc. The arrangement calls for a new entity to be incorporated to hold and manage the combined business of Reunion Gold and GMIN; the new entity will acquire all of…

Continue Reading

ThursdayJun 13, 2024 1:42 pm

QualityStocksNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) Signs Option Agreement with USC to Exclusively Evaluate Novel Technology for Commercialization

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, has entered into an exclusive option agreement with the University of Southern California (“USC”). Signed June 11, 2024, the option agreement allows FSD Pharma to exclusively evaluate, for an initial term of six months, a novel dietary supplement technology for commercialization. At the end of this term, the company will have the option to either extend it for a further six months or to sign an exclusive license with USC for the technology. The company is evaluating this novel…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered